GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetron Holdings Ltd (NAS:GTH) » Definitions » Piotroski F-Score

Genetron Holdings (Genetron Holdings) Piotroski F-Score

: 0 (As of Today)
View and export this data going back to 2020. Start your Free Trial

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Genetron Holdings has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Genetron Holdings's Piotroski F-Score or its related term are showing as below:


Genetron Holdings Piotroski F-Score Historical Data

The historical data trend for Genetron Holdings's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetron Holdings Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Piotroski F-Score
Premium Member Only N/A N/A 4.00 4.00 -

Genetron Holdings Quarterly Data
Dec17 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Dec22
Piotroski F-Score Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 4.00 4.00 2.00 -

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun22) TTM:Last Year (Jun21) TTM:
Net Income was -19.976 + -25.543 + -27.484 + -35.132 = $-108.14 Mil.
Cash Flow from Operations was 0 + 0 + 0 + 0 = $0.00 Mil.
Revenue was 23.627 + 23.058 + 17.388 + 20.574 = $84.65 Mil.
Gross Profit was 16.3 + 13.144 + 9.689 + 8.378 = $47.51 Mil.
Average Total Assets from the begining of this year (Jun21)
to the end of this year (Jun22) was
(271.984 + 255.877 + 238.271 + 209.412 + 194.672) / 5 = $234.0432 Mil.
Total Assets at the begining of this year (Jun21) was $271.98 Mil.
Long-Term Debt & Capital Lease Obligation was $7.34 Mil.
Total Current Assets was $147.83 Mil.
Total Current Liabilities was $52.29 Mil.
Net Income was -7.048 + -11.197 + -17.318 + -14.291 = $-49.85 Mil.

Revenue was 16.44 + 20.483 + 14.14 + 21.865 = $72.93 Mil.
Gross Profit was 10.224 + 12.864 + 8.378 + 14.703 = $46.17 Mil.
Average Total Assets from the begining of last year (Jun20)
to the end of last year (Jun21) was
(309.721 + 329.916 + 301.24 + 289.356 + 271.984) / 5 = $300.4434 Mil.
Total Assets at the begining of last year (Jun20) was $309.72 Mil.
Long-Term Debt & Capital Lease Obligation was $6.28 Mil.
Total Current Assets was $239.71 Mil.
Total Current Liabilities was $31.96 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Genetron Holdings's current Net Income (TTM) was -108.14. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Genetron Holdings's current Cash Flow from Operations (TTM) was 0.00. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Jun21)
=-108.135/271.984
=-0.39757853

ROA (Last Year)=Net Income/Total Assets (Jun20)
=-49.854/309.721
=-0.16096422

Genetron Holdings's return on assets of this year was -0.39757853. Genetron Holdings's return on assets of last year was -0.16096422. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Genetron Holdings's current Net Income (TTM) was -108.14. Genetron Holdings's current Cash Flow from Operations (TTM) was 0.00. ==> 0.00 > -108.14 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Jun22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun21 to Jun22
=7.343/234.0432
=0.03137455

Gearing (Last Year: Jun21)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun20 to Jun21
=6.278/300.4434
=0.02089578

Genetron Holdings's gearing of this year was 0.03137455. Genetron Holdings's gearing of last year was 0.02089578. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Jun22)=Total Current Assets/Total Current Liabilities
=147.832/52.291
=2.82710218

Current Ratio (Last Year: Jun21)=Total Current Assets/Total Current Liabilities
=239.709/31.962
=7.49981228

Genetron Holdings's current ratio of this year was 2.82710218. Genetron Holdings's current ratio of last year was 7.49981228. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Genetron Holdings's number of shares in issue this year was 30.906. Genetron Holdings's number of shares in issue last year was 30.66. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=47.511/84.647
=0.56128392

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=46.169/72.928
=0.63307646

Genetron Holdings's gross margin of this year was 0.56128392. Genetron Holdings's gross margin of last year was 0.63307646. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Jun21)
=84.647/271.984
=0.31122051

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Jun20)
=72.928/309.721
=0.23546353

Genetron Holdings's asset turnover of this year was 0.31122051. Genetron Holdings's asset turnover of last year was 0.23546353. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+0+0+0+0+1
=2

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Genetron Holdings has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

Genetron Holdings  (NAS:GTH) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Genetron Holdings Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Genetron Holdings's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Genetron Holdings (Genetron Holdings) Business Description

Traded in Other Exchanges
N/A
Address
No. 8 Life Science Parkway, 1-2nd Floor, Building 11, Zone 1, Changping District, Beijing, CHN, 102206
Genetron Holdings Ltd is an oncology company in China. It is specialized in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The company's operating segment includes Diagnosis and monitoring - provision for LDT services; Diagnosis and monitoring - sale of IVD products and Development services. It generates maximum revenue from the Diagnosis and monitoring - provision for LDT services segment.